Key Takeaways
What Is Respiratory Depression?
Respiratory depression is breathing that has become too slow, too shallow or both to move enough air. When breathing falls short, the lungs cannot easily move oxygen into the blood or remove carbon dioxide, so blood oxygen drops and carbon dioxide rises[2]. The clinical names for those two results are hypoxemia and hypercapnia.
The name causes confusion. Respiratory depression is not depression the mood disorder; "depression" here means a reduction in the drive to breathe. The two topics meet mainly through medications, because several drugs prescribed for anxiety and insomnia can suppress breathing, especially alongside opioids or alcohol[8][9].
The rhythm of breathing is generated in the brainstem. The preBötzinger complex in the medulla sets the inspiratory rhythm, and opioids act on mu-opioid receptors there and in the pons (the Kölliker-Fuse and parabrachial nuclei) to depress it[10]. Opioid-induced respiratory depression (OIRD) is the primary cause of opioid-induced death[10].
During an opioid overdose, the brain may stop detecting high carbon dioxide levels. Normally that signal triggers deeper breathing; instead, carbon dioxide builds up while oxygen falls, which can progress to respiratory failure[2].
Respiratory depression (hypoventilation)
A reduction in the rate or depth of breathing large enough to lower oxygen and raise carbon dioxide in the blood[2]. Drug-related respiratory depression comes from suppression of the brainstem's respiratory drive, which together with reduced consciousness and obstructive sleep apnea causes ventilatory insufficiency[10].
Related Terms
Source: NHLBI; Baldo and Rose, Archives of Toxicology, 2022
Is Respiratory Depression the Same as Depression?
No. Depression the mental health condition is a mood disorder, and its prevalence and treatment data are on the depression and major depressive disorder pages. Respiratory depression is a physical state measured with breathing rate, oxygen saturation and exhaled carbon dioxide[3].
The overlap is pharmacological. Benzodiazepines are FDA-approved for generalized anxiety disorder, panic disorder, social phobia, insomnia and seizures, and FDA states that combining them with opioids and other central nervous system (CNS) depressants has resulted in severe respiratory depression and death[8].
Sleep aids such as zolpidem and eszopiclone and benzodiazepines such as diazepam and alprazolam suppress the brain areas that control breathing, as alcohol does[9]. The drug classes themselves are covered in the guides to anxiety medication and sleeping pills.
Can anxiety cause respiratory depression?
Anxiety usually pushes breathing the other way. Hyperventilation is rapid, deep breathing that lowers carbon dioxide in the blood, and anxiety and panic attacks are among its listed causes[11]. Respiratory depression raises carbon dioxide instead[2].
For people with anxiety or panic disorder, the documented breathing risk comes from sedating medication, particularly benzodiazepines taken with opioids, alcohol or other CNS depressants[8].
What Causes Respiratory Depression?
Most drug-related cases involve CNS depressants, and risk climbs when they are combined. The main classes are listed below.
- Opioids. Opioids act on mu-opioid receptors in the brainstem's breathing centers[10]. Synthetic opioids such as fentanyl were involved in an estimated 38,084 U.S. overdose deaths in 2025[4].
- Benzodiazepines. Taken with opioids, they have caused severe respiratory depression and death, and FDA updated the class's boxed warning in 2020[8].
- Alcohol. At overdose levels, alcohol shuts down the brain areas that control breathing, heart rate and temperature, and combining it with opioids or sedative-hypnotics intensifies each drug's effects[9]. Prevalence data are on the alcohol use disorder page.
- Gabapentinoids. In 2019, FDA required respiratory depression warnings for gabapentin and pregabalin in patients with respiratory risk factors, including opioid use, other CNS depressants, chronic obstructive pulmonary disease (COPD) and older age[12].
- Sedation for surgery. Sedatives used during surgery affect breathing, with higher risk in people who have other risk factors[2].
Not every case is drug-induced. Stroke, spinal cord injury and nerve and muscle disorders such as ALS, Guillain-Barré syndrome and myasthenia gravis can also leave breathing inadequate[2].
Obstructive sleep apnea adds to the effect of opioids on breathing[10]. Data on the condition are on the sleep apnea page, and its main treatment is reviewed in CPAP therapy for OSA.
Drug Classes Linked to Respiratory Depression
| Drug class | Examples | Common uses | Federal warning |
|---|---|---|---|
| Opioids | Fentanyl, opioid pain relievers | Pain | Boxed warning on use with benzodiazepines (FDA, 2016) |
| Benzodiazepines | Alprazolam, diazepam | Anxiety, panic, insomnia, seizures | Boxed warning updated (FDA, 2020) |
| Gabapentinoids | Gabapentin, pregabalin | Seizures, nerve pain | Respiratory depression warning (FDA, 2019) |
| Sleep aids | Zolpidem, eszopiclone | Insomnia | Overdose risk with alcohol (NIAAA) |
| Alcohol | Beer, wine, spirits | Not applicable | Overdose suppresses breathing centers (NIAAA) |
Drug classes that federal agencies identify as able to suppress breathing, with examples, common uses and the related warning[13][8][12][9].
1Risk rises when two or more CNS depressants are taken together[5][9].
2Common uses reflect FDA-approved indications or labeling described in the cited communications; the list is not exhaustive.
Sources
- •FDA, 2016, 2019, 2020
- •NIAAA
- •NIDA, 2024
Signs and Symptoms of Respiratory Depression
FDA's list of warning signs for drug-related breathing problems includes confusion or disorientation, unusual dizziness or lightheadedness, extreme sleepiness, slowed, shallow or difficult breathing, unresponsiveness, and bluish skin, especially on the lips, fingers and toes[12].
For a suspected opioid overdose, CDC lists unconsciousness or inability to wake, slow or shallow breathing, choking or gurgling and snoring sounds, discolored lips or nails, and small "pinpoint" pupils that do not react to light[7].
What breathing rate counts as respiratory depression?
No single cutoff is used everywhere. A normal adult resting rate is 12 to 20 breaths per minute[1]. NIAAA lists fewer than 8 breaths per minute, or 10 seconds or more between breaths, among the critical signs of alcohol overdose[9].
Research definitions are stricter and combine several measures. The PRODIGY trial counted an episode when respiratory rate was 5 breaths per minute or lower, oxygen saturation was 85% or lower, or end-tidal carbon dioxide was 15 mm Hg or lower or 60 mm Hg or higher for at least 3 minutes, or when breathing stopped for more than 30 seconds[3].
How Common Is Respiratory Depression in Hospital Patients?
Episodes are common once breathing is monitored continuously. In the international PRODIGY trial, 614 of 1,335 general ward patients (46%) receiving parenteral opioids had one or more respiratory depression episodes during a median of 24 hours of continuous capnography and oximetry[3].
Five factors independently predicted episodes: age 60 or older, sex, opioid naivety, sleep disorders and chronic heart failure[3]. FDA separately lists COPD and older age as risk factors for breathing problems with gabapentinoids[12].
Patients with at least one episode stayed in the hospital about 3 days longer on average (10.5 vs. 7.7 days)[3]. That is an association; the study does not show the episodes caused the longer stays.
The trial measured hospital patients only. For the general population, overdose death counts are the closest available measure.
Hospital ward patients on parenteral opioids with at least one respiratory depression episode
Measured with continuous capnography and pulse oximetry over a median of 24 hours in 1,335 patients in the international PRODIGY trial.
"One or more respiratory depression episodes were detected in 614 (46%) of 1335 general care floor patients"
Respiratory Depression and Overdose Deaths
According to NIDA, suppressed breathing is the cause of death in overdose, and both opioids and benzodiazepines can produce it[5]. Provisional CDC data estimate 69,973 U.S. drug overdose deaths in 2025, down almost 14% from 81,313 in 2024[4].
Deaths involving opioids fell from an estimated 55,296 to 44,564 over the same period, and deaths involving synthetic opioids such as fentanyl fell from 48,913 to 38,084[4]. State trends are in opioid crisis by state, and data on the underlying disorder are on the opioid use disorder page.
Combinations raise the risk. In 2021, nearly 14% of opioid-involved overdose deaths also involved benzodiazepines, and a North Carolina cohort found an overdose death rate 10 times higher among patients receiving both drug types than among those receiving opioids only[5].
In 2016, FDA required boxed warnings on nearly 400 opioid pain, opioid cough and benzodiazepine products about combined use, whose risks include extreme sleepiness, respiratory depression, coma and death[13].
Estimated U.S. Drug Overdose Deaths by Drug Type, 2024 and 2025
| Drug involved | 2024 | 2025 | Change |
|---|---|---|---|
| All drug overdose deaths | 81,313 | 69,973 | -13.9% |
| Any opioid | 55,296 | 44,564 | -19.4% |
| Synthetic opioids (fentanyl) | 48,913 | 38,084 | -22.1% |
| Natural/semi-synthetic opioids | 8,082 | 7,065 | -12.6% |
| Psychostimulants (incl. methamphetamine) | 29,852 | 26,181 | -12.3% |
| Cocaine | 22,397 | 19,581 | -12.6% |
Estimated drug overdose deaths in the United States by drug involved, 2024 and 2025, from provisional National Vital Statistics System data[4].
1Deaths may involve more than one drug, so categories overlap and do not sum to the total[4].
22025 figures are provisional and subject to change as more data are submitted[4].
3Change column calculated by mhstats.org from the published estimates.
Sources
- •NCHS, 2026
How Respiratory Depression Is Detected and Treated
In hospitals, detection depends on monitoring. PRODIGY paired continuous capnography, which tracks exhaled carbon dioxide, with pulse oximetry, which tracks oxygen saturation[3].
For opioid-induced cases, the standard treatment is naloxone, which rapidly reverses the effects of opioid overdose[6]. FDA first approved Narcan nasal spray as a prescription drug in 2015 and approved it for over-the-counter sale on March 29, 2023[6].
Naloxone has limits. It also reverses pain relief, and mismatches between the half-lives of naloxone and the opioid involved can make respiratory depression difficult to control safely[10].
For bystanders, CDC's guidance is to give naloxone if available, call 911, try to keep the person awake and breathing, lay them on their side to prevent choking and stay until emergency help arrives[7]. CDC notes that most states have laws that may protect the person overdosing, or the person who called for help, from criminal penalties[7].
Prescribing safeguards
FDA tells clinicians to start gabapentinoids at the lowest dose and to monitor for respiratory depression and sedation when co-prescribing them with an opioid or a benzodiazepine[12]. Its benzodiazepine communication calls for particular caution when combining those drugs with opioids and other CNS depressants[8].
Frequently Asked Questions
Sources & References
- Rapid shallow breathing. MedlinePlus Medical Encyclopedia, National Library of Medicine. Published 2025. Accessed October 2026. https://medlineplus.gov/ency/article/007198.htm [Link]
- Respiratory Failure: Causes and Risk Factors. National Heart, Lung, and Blood Institute. Published 2022. Accessed October 2026. https://www.nhlbi.nih.gov/health/respiratory-failure/causes [Link]
- Khanna AK, Bergese SD, Jungquist CR, et al. Prediction of Opioid-Induced Respiratory Depression on Inpatient Wards Using Continuous Capnography and Oximetry: An International Prospective, Observational Trial. Anesthesia & Analgesia. Published 2020. Accessed October 2026. https://doi.org/10.1213/ANE.0000000000004788 [Link]
- U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025. National Center for Health Statistics. Published 2026. Accessed October 2026. https://www.cdc.gov/nchs/pressroom/releases/20260513.html [Link]
- Benzodiazepines and Opioids. National Institute on Drug Abuse. Published 2024. Accessed October 2026. https://nida.nih.gov/research-topics/opioids/benzodiazepines-opioids [Link]
- FDA Approves First Over-the-Counter Naloxone Nasal Spray. U.S. Food and Drug Administration. Published 2023. Accessed October 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray [Link]
- What to Do If You Think Someone Is Overdosing. Centers for Disease Control and Prevention. Published 2024. Accessed October 2026. https://www.cdc.gov/stop-overdose/response/index.html [Link]
- FDA Drug Safety Communication: FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. U.S. Food and Drug Administration. Published 2020. Accessed October 2026. https://www.fda.gov/media/142368/download [Link]
- Understanding the Dangers of Alcohol Overdose. National Institute on Alcohol Abuse and Alcoholism. Accessed October 2026. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-dangers-of-alcohol-overdose [Link]
- Baldo BA, Rose MA. Mechanisms of opioid-induced respiratory depression. Archives of Toxicology. Published 2022. Accessed October 2026. https://doi.org/10.1007/s00204-022-03300-7 [Link]
- Hyperventilation. MedlinePlus Medical Encyclopedia, National Library of Medicine. Published 2024. Accessed October 2026. https://medlineplus.gov/ency/article/003071.htm [Link]
- Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug Safety Communication - Serious Breathing Problems. U.S. Food and Drug Administration. Published 2019. Accessed October 2026. https://www.fda.gov/safety/medical-product-safety-information/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication [Link]
- New Safety Measures Announced for Opioid Analgesics, Prescription Opioid Cough Products, and Benzodiazepines. U.S. Food and Drug Administration. Published 2016. Accessed October 2026. https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and [Link]